サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1065818

タンパク質工学の世界市場：業界動向、シェア、規模、成長、機会、予測（2022年～2027年）

Protein Engineering Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 145 Pages | 納期: 2～3営業日
AI翻訳ツール 提供対象
ご購入後の翻訳ツール提供について

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
タンパク質工学の世界市場：業界動向、シェア、規模、成長、機会、予測（2022年～2027年）
出版日: 2022年03月15日
発行: IMARC Services Private Limited
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のタンパク質工学の市場規模は、2021年に26億1,000万米ドルとなり、2022年～2027年の間に11.60%のCAGRで成長し、2027年までに51億8,000万米ドルに達すると予測されています。

市場成長の主な要因は、合成生物学への投資の増加とタンパク質医薬品開発への注力です。加えて、非タンパク質医薬品からタンパク質治療法へのシフト、各国政府によるタンパク質工学の研究開発（R&D）活動への資金提供の増加などの有益な取り組み、組み換えモノクローナル抗体（mAbs）の登場やさまざまな疾患の治療におけるモノクローナル抗体の利用拡大による製品採用率の増加が、市場の成長を後押ししています。さらに、農薬産業におけるタンパク質工学の応用研究、個別化医療に対する需要の高まり、バイオシミラーや生物製剤に対するニーズの高まり、医療インフラの改善、技術の進歩、製品のイノベーションなども、市場に明るい展望をもたらしています。

当レポートでは、世界のタンパク質工学市場について調査分析し、市場概要、セグメント別・地域別の市場分析、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のタンパク質工学市場

  • 市場概要
  • 市場実績
  • COVID-19の影響

第6章 市場の内訳：製品・サービス別

  • 器具
  • 試薬
  • サービス・ソフトウェア

第7章 市場の内訳：タンパク質タイプ別

  • インスリン
  • モノクローナル抗体
  • 凝固因子
  • ワクチン
  • 成長因子
  • その他

第8章 市場の内訳：技術別

  • 非合理的タンパク質設計
  • 合理的タンパク質設計

第9章 市場の内訳：エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • 開発業務委託機関

第10章 市場の内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 国別の市場内訳

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Abzena Ltd.
    • Agilent Technologies Inc.
    • Amgen Inc.
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Codexis Inc.
    • Danaher Corporation
    • Eli Lilly and Company
    • General Electric Company
    • Merck KGaA
    • Novo Nordisk A/S
    • PerkinElmer Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Protein Engineering Market: Major Drivers and Challenges
  • Figure 2: Global: Protein Engineering Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Protein Engineering Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 4: Global: Protein Engineering Market: Breakup by Product & Services (in %), 2021
  • Figure 5: Global: Protein Engineering Market: Breakup by Protein Type (in %), 2021
  • Figure 6: Global: Protein Engineering Market: Breakup by Technology (in %), 2021
  • Figure 7: Global: Protein Engineering Market: Breakup by End User (in %), 2021
  • Figure 8: Global: Protein Engineering Market: Breakup by Region (in %), 2021
  • Figure 9: Global: Protein Engineering (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 10: Global: Protein Engineering (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 11: Global: Protein Engineering (Reagents) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 12: Global: Protein Engineering (Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 13: Global: Protein Engineering (Services and Software) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 14: Global: Protein Engineering (Services and Software) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 15: Global: Protein Engineering (Insulin) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 16: Global: Protein Engineering (Insulin) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 17: Global: Protein Engineering (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 18: Global: Protein Engineering (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 19: Global: Protein Engineering (Coagulation Factors) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 20: Global: Protein Engineering (Coagulation Factors) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 21: Global: Protein Engineering (Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 22: Global: Protein Engineering (Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 23: Global: Protein Engineering (Growth Factors) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 24: Global: Protein Engineering (Growth Factors) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 25: Global: Protein Engineering (Other Protein Types) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 26: Global: Protein Engineering (Other Protein Types) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 27: Global: Protein Engineering (Irrational Protein Design) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 28: Global: Protein Engineering (Irrational Protein Design) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 29: Global: Protein Engineering (Rational Protein Design) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 30: Global: Protein Engineering (Rational Protein Design) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 31: Global: Protein Engineering (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 32: Global: Protein Engineering (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 33: Global: Protein Engineering (Academic Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 34: Global: Protein Engineering (Academic Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 35: Global: Protein Engineering (Contract Research Organizations) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 36: Global: Protein Engineering (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 37: North America: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 38: North America: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 39: United States: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 40: United States: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 41: Canada: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 42: Canada: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 43: Asia-Pacific: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 44: Asia-Pacific: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 45: China: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 46: China: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 47: Japan: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 48: Japan: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 49: India: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 50: India: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 51: South Korea: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 52: South Korea: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 53: Australia: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 54: Australia: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 55: Indonesia: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 56: Indonesia: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 57: Others: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 58: Others: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 59: Europe: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 60: Europe: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 61: Germany: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 62: Germany: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 63: France: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 64: France: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 65: United Kingdom: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 66: United Kingdom: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 67: Italy: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 68: Italy: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 69: Spain: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 70: Spain: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 71: Russia: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 72: Russia: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 73: Others: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 74: Others: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 75: Latin America: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 76: Latin America: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 77: Brazil: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 78: Brazil: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 79: Mexico: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 80: Mexico: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 81: Others: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 82: Others: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 83: Middle East and Africa: Protein Engineering Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 84: Middle East and Africa: Protein Engineering Market: Breakup by Country (in %), 2021
  • Figure 85: Middle East and Africa: Protein Engineering Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 86: Global: Protein Engineering Industry: SWOT Analysis
  • Figure 87: Global: Protein Engineering Industry: Value Chain Analysis
  • Figure 88: Global: Protein Engineering Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Protein Engineering Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Protein Engineering Market Forecast: Breakup by Product & Services (in Million US$), 2022-2027
  • Table 3: Global: Protein Engineering Market Forecast: Breakup by Protein Type (in Million US$), 2022-2027
  • Table 4: Global: Protein Engineering Market Forecast: Breakup by Technology (in Million US$), 2022-2027
  • Table 5: Global: Protein Engineering Market Forecast: Breakup by End User (in Million US$), 2022-2027
  • Table 6: Global: Protein Engineering Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 7: Global: Protein Engineering Market: Competitive Structure
  • Table 8: Global: Protein Engineering Market: Key Players
目次
Product Code: SR0322A88_Report

The global protein engineering market reached a value of US$ 2.61 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 5.18 Billion by 2027 exhibiting a CAGR of 11.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Protein engineering refers to the process of developing or changing a protein sequence to achieve the desired result. It involves the synthesis of new proteins or amendments in the existing structure or sequence and employs recombinant deoxyribonucleic acid (DNA) technology to alter amino acid sequences for novel and enhanced functions. It is widely utilized for the production of enzymes or proteins in large quantities for use in industrial settings. In recent years, researchers have successfully engineered a wide range of proteins tailored to medicine, research, industry, health, and biotechnology applications, which is escalating their demand across the globe.

Protein Engineering Market Trends:

  • The rising investments in synthetic biology and the improving focus toward protein-based drug development represent the primary factors driving the market growth. Additionally, there has been a significant shift toward protein therapeutics from non-protein drugs due to their associated positive clinical outcomes. This, in confluence with the widespread prevalence of protein-deficient diseases, is increasing the demand for protein engineering. Furthermore, several favorable initiatives undertaken by the government of various countries, such as increased funding for research and development (R&D) activities in the field of protein engineering, are propelling the market growth. Besides this, the advent of recombinant monoclonal antibodies (mAbs) and the increasing usage of monoclonal antibodies to treat various diseases, such as cancer and autoimmune diseases, are accelerating product adoption rates. Moreover, the ongoing research for applications of protein engineering in the agrochemical industry to generate enzymes with enhanced function to increase the crop yield or facilitate biofuel production is catalyzing the market growth. Other factors, including the escalating demand for personalized medicines, growing need for biosimilars and biologics, improving healthcare infrastructure, technological advancements, and product innovations, are also creating a positive outlook for the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global protein engineering market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product & services, protein type, technology and end user.

Breakup by Product & Services:

  • Instruments
  • Reagents
  • Services and Software

Breakup by Protein Type:

  • Insulin
  • Monoclonal Antibodies
  • Coagulation Factors
  • Vaccines
  • Growth Factors
  • Others

Breakup by Technology:

  • Irrational Protein Design
  • Rational Protein Design

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abzena Ltd., Agilent Technologies Inc., Amgen Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Codexis Inc., Danaher Corporation, Eli Lilly and Company, General Electric Company, Merck KGaA, Novo Nordisk A/S, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Waters Corporation. Key Questions Answered in This Report:

  • How has the global protein engineering market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global protein engineering market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product & services?
  • What is the breakup of the market based on the protein type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global protein engineering market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Protein Engineering Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product & Services

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services and Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Protein Type

  • 7.1 Insulin
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Coagulation Factors
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vaccines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Growth Factors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Irrational Protein Design
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Rational Protein Design
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organizations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abzena Ltd.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amgen Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bio-Rad Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Bruker Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Codexis Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Eli Lilly and Company
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 General Electric Company
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Merck KGaA
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Novo Nordisk A/S
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 PerkinElmer Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Waters Corporation
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis